文献速递泌尿生殖妇产影像CT

基于治疗前CT纹理的瘤间异质性新表示方法可通过临床结局对卵巢癌进行分类

A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome.
PubMed 文献 · Eur Radiol · 2017-03-13

本研究纳入38例高级别浆液性卵巢癌患者,基于术前CT手动分割所有可疑病灶,计算灰度相关矩阵纹理并用高斯混合模型聚类,构建瘤间相似性矩阵并提取纹理异质性指标。结果显示部分瘤间纹理异质性指标与总生存期缩短和不完全手术切除相关,且CCNE1扩增主要见于瘤间纹理更异质的患者。

要点

  • 瘤间纹理相似性熵、相似性水平聚类阴影和瘤间相似性水平聚类突出度与总生存期缩短相关(p≤0.05)。
  • 相似性水平聚类阴影、瘤间相似性水平聚类突出度和瘤间聚类方差与不完全手术切除相关(p≤0.05)。
  • 患者病灶总数和总肿瘤体积均与总生存期无关。

核心结论

  • 无创定量捕捉瘤间空间异质性的指标可能预测高级别浆液性卵巢癌患者的结局。

研究设计与样本

  • IRB批准的回顾性研究,纳入38例高级别浆液性卵巢癌患者,术前CT上所有可疑病灶均手动分割,基于灰度相关矩阵计算纹理并用高斯混合模型聚为五类,构建瘤间相似性矩阵。

诊断标准与关键数值

  • 评估了12项瘤间纹理异质性指标,其中与总生存期缩短相关的指标为瘤间相似性熵、相似性水平聚类阴影和瘤间相似性水平聚类突出度(p≤0.05)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the associations between clinical outcomes and radiomics-derived inter-site spatial heterogeneity metrics across multiple metastatic lesions on CT in patients with high-grade serous ovarian cancer (HGSOC).

METHODS: IRB-approved retrospective study of 38 HGSOC patients. All sites of suspected HGSOC involvement on preoperative CT were manually segmented. Gray-level correlation matrix-based textures were computed from each tumour site, and grouped into five clusters using a Gaussian Mixture Model. Pairwise inter-site similarities were computed, generating an inter-site similarity matrix (ISM). Inter-site texture heterogeneity metrics were computed from the ISM and compared to clinical outcomes.

RESULTS: Of the 12 inter-site texture heterogeneity metrics evaluated, those capturing the differences in texture similarities across sites were associated with shorter overall survival (inter-site similarity entropy, similarity level cluster shade, and inter-site similarity level cluster prominence; p ≤ 0.05) and incomplete surgical resection (similarity level cluster shade, inter-site similarity level cluster prominence and inter-site cluster variance; p ≤ 0.05). Neither the total number of disease sites per patient nor the overall tumour volume per patient was associated with overall survival. Amplification of 19q12 involving cyclin E1 gene (CCNE1) predominantly occurred in patients with more heterogeneous inter-site textures.

CONCLUSION: Quantitative metrics non-invasively capturing spatial inter-site heterogeneity may predict outcomes in patients with HGSOC.

KEY POINTS: • Calculating inter-site texture-based heterogeneity metrics was feasible • Metrics capturing texture similarities across HGSOC sites were associated with overall survival • Heterogeneity metrics were also associated with incomplete surgical resection of HGSOC.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Vargas HA, Veeraraghavan H, Micco M, et al. A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome. Eur Radiol. 2017. PMID: 28289945. doi:10.1007/s00330-017-4779-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。